Literature DB >> 22773374

Helicobacter pylori, a carcinogen, induces the expression of melanoma antigen-encoding gene (Mage)-A3, a cancer/testis antigen.

Takashi Fukuyama1, Taiga Yamazaki, Tomoko Fujita, Takayuki Uematsu, Yoshinobu Ichiki, Hiroshi Kaneko, Tatsuo Suzuki, Noritada Kobayashi.   

Abstract

Cancer/testis antigens (CTAs) are known to be expressed in various cancer types but are minimally or not expressed in normal tissues except for germline tissues. CTAs are attractive targets for cancer immunotherapy and diagnosis because of their restricted expression. The mechanisms of CTAs expression are unclear because the inducers of CTAs expression remain to be elucidated. We hypothesized that carcinogens may induce the cellular expression of CTAs. To prove this, we attempted to inoculate Helicobacter pylori, a known carcinogen, in Meth-A cells, normal gastric cells, and normal splenocytes and induce the expression of a CTA. Melanoma antigen-encoding gene (Mage)-A3, one of the CTAs, was not expressed in both normal cells but in Meth-A cells inoculated with H. pylori. Furthermore, we performed limiting dilution using Meth-A cells inoculated with H. pylori and established derivative clone from Meth-A designated as Meth-A/pylori/3C3 which permanently express Mage-A3 after excluding H. pylori. We herein report the first successful induction of a CTA in a cell line via exposure to a carcinogenic agent. Furthermore, the establishment of Meth-A/pylori/3C3, which is Meth-A expressing Mage-A3, is considered to contribute to the resolution of the mechanism of CTAs expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22773374     DOI: 10.1007/s13277-012-0448-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  16 in total

1.  MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma.

Authors:  Irma Olarte; Adolfo Martinez; Christian Ramos-Peñafiel; Humberto Castellanos-Sinco; Jorge Zamora; Juan Collazo-Jaloma; Mario Gutiérrez; Laila Gutiérrez-Kobeh; Pedro Chavez-Olmos; Hugo Manzanilla; Efraín Garrido-Guerrero; Rosa M Ordoñez-Razo; Enrique I Miranda
Journal:  Hematology       Date:  2011-11       Impact factor: 2.269

2.  MicroRNA signatures in Helicobacter pylori-infected gastric mucosa.

Authors:  Kayoko Matsushima; Hajime Isomoto; Naoki Inoue; Toshiyuki Nakayama; Tomayoshi Hayashi; Masaaki Nakayama; Kazuhiko Nakao; Toshiya Hirayama; Shigeru Kohno
Journal:  Int J Cancer       Date:  2010-03-23       Impact factor: 7.396

3.  Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells.

Authors:  Fabio Bagnoli; Ludovico Buti; Lucy Tompkins; Antonello Covacci; Manuel R Amieva
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-28       Impact factor: 11.205

4.  DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter.

Authors:  C De Smet; C Lurquin; B Lethé; V Martelange; T Boon
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

5.  Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells.

Authors:  N Murata-Kamiya; Y Kurashima; Y Teishikata; Y Yamahashi; Y Saito; H Higashi; H Aburatani; T Akiyama; R M Peek; T Azuma; M Hatakeyama
Journal:  Oncogene       Date:  2007-01-22       Impact factor: 9.867

6.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

Review 7.  The cancer/testis genes: review, standardization, and commentary.

Authors:  Matthew J Scanlan; Andrew J G Simpson; Lloyd J Old
Journal:  Cancer Immun       Date:  2004-01-23

8.  Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA.

Authors:  Manuel R Amieva; Roger Vogelmann; Antonello Covacci; Lucy S Tompkins; W James Nelson; Stanley Falkow
Journal:  Science       Date:  2003-05-30       Impact factor: 47.728

9.  The long noncoding RNA, Jpx, is a molecular switch for X chromosome inactivation.

Authors:  Di Tian; Sha Sun; Jeannie T Lee
Journal:  Cell       Date:  2010-10-29       Impact factor: 41.582

10.  Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.

Authors:  J Weber; M Salgaller; D Samid; B Johnson; M Herlyn; N Lassam; J Treisman; S A Rosenberg
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

View more
  9 in total

Review 1.  Current status of immunotherapy and immune biomarkers in gastro-esophageal cancers.

Authors:  Nischala Ammannagari; Ajlan Atasoy
Journal:  J Gastrointest Oncol       Date:  2018-02

Review 2.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

3.  Correlation Between Expression of the Cancer/Testis Antigen KK-LC-1 and Helicobacter pylori Infection in Gastric Cancer.

Authors:  Takashi Fukuyama; Nobue Futawatari; Yoshinobu Ichiki; Akiko Shida; Taiga Yamazaki; Yatsushi Nishi; Hiroshi Nonoguchi; Yoshihito Takahashi; Hitoshi Yamazaki; Noritada Kobayashi
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

4.  MAEL Cancer-Testis Antigen as a Diagnostic Marker in Primary Stages of Gastric Cancer with Helicobacter pylori Infection.

Authors:  Mohammad Reza Abbaszadegan; Negin Taghehchian; Azadeh Aarabi; Meysam Moghbeli
Journal:  J Gastrointest Cancer       Date:  2020-03

Review 5.  Emerging roles of the MAGE protein family in stress response pathways.

Authors:  Rebecca R Florke Gee; Helen Chen; Anna K Lee; Christina A Daly; Benjamin A Wilander; Klementina Fon Tacer; Patrick Ryan Potts
Journal:  J Biol Chem       Date:  2020-09-13       Impact factor: 5.157

Review 6.  Immunotherapy for Gastric Cancer: A Focus on Immune Checkpoints.

Authors:  Maria Alsina; Markus Moehler; Cinta Hierro; Raquel Guardeño; Josep Tabernero
Journal:  Target Oncol       Date:  2016-08       Impact factor: 4.493

Review 7.  The Future Prospects of Immune Therapy in Gastric and Esophageal Adenocarcinoma.

Authors:  Walid L Shaib; Jean Paul A Nammour; Harpaul Gill; Mayur Mody; Nabil F Saba
Journal:  J Clin Med       Date:  2016-11-14       Impact factor: 4.241

8.  Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen.

Authors:  Nobue Futawatari; Takashi Fukuyama; Rui Yamamura; Akiko Shida; Yoshihito Takahashi; Yatsushi Nishi; Yoshinobu Ichiki; Noritada Kobayashi; Hitoshi Yamazaki; Masahiko Watanabe
Journal:  World J Gastroenterol       Date:  2017-12-14       Impact factor: 5.742

9.  Expression of KK-LC-1, a cancer/testis antigen, at non-tumour sites of the stomach carrying a tumour.

Authors:  Takashi Fukuyama; Nobue Futawatari; Rui Yamamura; Taiga Yamazaki; Yoshinobu Ichiki; Akira Ema; Hideki Ushiku; Yatsushi Nishi; Yoshihito Takahashi; Toshikazu Otsuka; Hitoshi Yamazaki; Wasaburo Koizumi; Kosei Yasumoto; Noritada Kobayashi
Journal:  Sci Rep       Date:  2018-04-17       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.